Navigation Links
Basilea Reports Positive Re-treatment Results from a Second Phase,III Trial of Alitretinoin for Patients with Severe Chronic Hand,Eczema

and therefore pregnancy prevention measures must be in place for all women of child-bearing potential who receive alitretinoin. Within days after discontinuation of therapy, alitretinoin levels return to endogenous levels. In clinical studies the post-treatment contraceptive period was four weeks.

About Basilea Basilea Pharmaceutica Ltd. is an independent biopharmaceutical company headquartered in Basel, Switzerland, and listed on the SWX Swiss Exchange (SWX:BSLN). Basilea's fully integrated research and development operations are currently focused on new antibacterial and antifungal agents to fight drug resistance and on the development of dermatology drugs. Basilea's products are targeted to satisfy high medical and patient needs in the hospital and specialty care setting. The company owns a diversified portfolio including three investigational phase III drugs of which two have shown positive pivotal phase III results. The company is integrating commercialization into its organization, in a first step through co-promoting ceftobiprole with its partner Cilag GmbH International, a Johnson & Johnson company, in North America and major European countries.

Disclaimer This communication expressly or implicitly contains certain forward-looking statements concerning Basilea Pharmaceutica Ltd. and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Basilea Pharmaceutica Ltd. to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Basilea Pharmaceutica Ltd. is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

For further information, please contact:

General Information | Investor Relations
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Efficacy and Safety Profile of Basileas Alitretinoin for Severe Refractory Chronic Hand Eczema Confirmed by Data Shown at European Dermatology Congress
2. Scientific Results Presented At ECCMID Demonstrate Well- Differentiated Profile of Basileas Two Phase III Anti- infective Compounds
3. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
4. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
5. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
8. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
9. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
10. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
11. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
Post Your Comments:
(Date:5/5/2015)... Ardelyx, Inc. (NASDAQ: ARDX ), ... and metabolic diseases, today announced that a 154-patient ... 3 chronic kidney disease patients with type 2 ... primary endpoint of decreasing the urinary albumin-creatinine ratio ... Ardelyx formed a partnership with ...
(Date:5/5/2015)... May 5, 2015 /CNW Telbec/ - Ergoresearch Ltd ... and known under the « Équilibre, ... of the transaction previously announced on April 23, 2015 ... outstanding  shares of Orthoconcept (2008) inc.   ... common shares (TSXV: ERG) to the vending shareholder, namely ...
(Date:5/5/2015)... , May 5, 2015  The preclinical contract research ... pharmacokinetic testing of drugs and safety testing of medical ... Director of Preclinical Studies, presented at this week,s annual ... Ophthalmology (ARVO) in Denver, CO. ... Assessment of a Novel, Cross-Linked, Bio-Absorbable Carboxymethyl Hyaluronic Acid ...
Breaking Medicine Technology:Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 4Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 5Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 6Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 2Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 3Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 2Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 3
(Date:5/5/2015)... May 05, 2015 NCPDP announced today ... Program. The program establishes a three-year commitment of strategic ... of 10 Elite Partners. “AmerisourceBergen has supported our multi-stakeholder ... of NCPDP, “and this is a wonderful continuation and ... We can trace AmerisourceBergen back to our very first ...
(Date:5/5/2015)... DC (PRWEB) May 05, 2015 ... Optimity) will present at the 24th ... at 1:15 p.m. MT in Scottsdale, AZ. WEDI, ... nation’s leading nonprofit authority on the use of ... exchange. Donald Graf, National Director of Telemedicine for ...
(Date:5/5/2015)... May 05, 2015 Viverae®, a ... Bard Inc., a leading multinational developer, manufacturer and ... fields of vascular, urology, oncology and surgical specialty ... Award. The Vanguard Award recognizes outstanding achievement ... programs among Viverae’s significant client base. , Viverae ...
(Date:5/5/2015)... Los Angeles, CA (PRWEB) May 05, 2015 ... to treat and actually prevent a variety of health ... Doc utilized this modern research to adopt clean eating ... preservatives and artificial dyes associated with over-consumption of fast ... eating diet plans easy to follow and report ...
(Date:5/5/2015)... TX (PRWEB) May 05, 2015 MAP ... programs and revenue cycle management for addiction treatment facilities, ... as Vice President of Business Development. Mr. Mooney, who ... addiction treatment field, will be responsible for developing new ... distribution of MAP’s core products and new initiatives. , ...
Breaking Medicine News(10 mins):Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3Health News:Optimity Advisors’ Hiliary Critchley, Telemedicine Expert, to Speak at WEDI Conference May 20th in Scottsdale, AZ 2Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 2Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 3Health News:Jimmy Mooney, an Addiction Treatment Veteran, Named Vice President of Business Development at MAP Health Management, LLC 2
... from oocytes (eggs) cryopreserved by the vitrification method are ... those involving fresh oocytes, the 26th annual meeting of ... today. Dr. Ana Cobo, Cryobiology Unit director at Institut ... the results of her team,s research would make egg ...
... ... Presence Catering to Members in all 50 States. , ... (PRWEB) June 30, 2010 -- MedTouch , a leading provider ... revitalized online presence for Sterling Life Insurance Company . The new website includes a ...
... ... Ondine Biopharma Corporation, a medical technology company developing photodisinfection ... owned subsidiary, “Sinuwave Technologies Corporation”, dedicated to the development and ... market. The subsidiary will license technology developed by Ondine Biopharma ...
... ... shortest skirts at Wimbledon. , ... London (PRWEB) June 30, 2010 -- With the tennis season now firmly underway, leading voucher ... tennis players to reveal the top five shortest tennis skirts at Wimbledon this tournament., , ...
... Lexington Health Care ... facilities in the Chicago area. OnShift enabled the company to reduce overtime by 71% in ... ... and employee communication software, recently announced it had been selected by Lexington Health Care ( ...
... ... ... their independence from tobacco cigarettes with a new e-cigarette system offered exclusively from PrimeVapor.com., , ... for smokers who want an alternative to inhaling a lit tobacco cigarette that is ...
Cached Medicine News:Health News:Ongoing pregnancy rates from vitrified eggs as good as those from fresh 2Health News:MedTouch Launches Revitalized Website for Sterling Life Insurance Company 2Health News:MedTouch Launches Revitalized Website for Sterling Life Insurance Company 3Health News:Ondine Biopharma Announces Sinuwave Technologies Spinout 2Health News:Ondine Biopharma Announces Sinuwave Technologies Spinout 3Health News:All Eyes on Hemlines, Not Henman, at Wimbledon This Year 2Health News:Lexington Health Care Chooses OnShift for Nurse Scheduling and Employee Communications in all Facilities 2Health News:Lexington Health Care Chooses OnShift for Nurse Scheduling and Employee Communications in all Facilities 3Health News:Electronic Cigarettes and the Declaration of Independence 2
Fisherbrand* Micro Slide Storage Cabinets and Bases (New), available in dark beige, tan, green, or white. Optional bases available with or without legs....
Fisherbrand* Micro Slide Cabinet is made of heavy gauge, reinforced steel....
... special drawers for just about everything imaginable that ... laboratory. Each box is designed for long term ... advantages of wood over metal systems is overlooked, ... a subtle kind of desiccator and insulator, providing ...
Allows for the organized storage of blocks that have been embedded using: Tissue Cassettes, Biopsy Cassettes, Mesh Cassettes, Mega Cassettes, Processing/Embedding Cassettes and Embedding Rings....
Medicine Products: